<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> is a common complication of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This cross-sectional study investigated the prevalence and clinical characteristics of this <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> in patients with Type 2 diabetic mellitus treated at hospitals in Korea </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Questionnaires and medical records were used to collect data on 4000 patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> from the <z:mp ids='MP_0002055'>diabetes</z:mp> clinics of 40 hospitals throughout Korea </plain></SENT>
<SENT sid="3" pm="."><plain>Diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> was diagnosed based on a review of medical records or using the Michigan <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">Neuropathy</z:e> Screening Instrument score and monofilament test </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> was 33.5% (n = 1338) </plain></SENT>
<SENT sid="5" pm="."><plain>Multivariate analysis revealed that age, female sex, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, lower glycated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi>, treatment with oral hypoglycaemic agents or insulin, presence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, history of cerebrovascular or <z:hpo ids='HP_0004950'>peripheral arterial disease</z:hpo>, presence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, and history of foot <z:mpath ids='MPATH_579'>ulcer</z:mpath> were independently associated with diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Of the patients with <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, 69.8% were treated for the condition and only 12.6% were aware of their <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: There was a high prevalence of <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Korea and those patients were far more likely to have complications or co-morbidities </plain></SENT>
<SENT sid="8" pm="."><plain>The proper management of diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> deserves attention from clinicians to ensure better management of <z:mp ids='MP_0002055'>diabetes</z:mp> in Korea </plain></SENT>
</text></document>